Low GFR amplifies the association between coronary three-vessel disease and all-cause mortality

Pamela Piscitelli1, Maria M D'Errico1, Antonio Mirijello1

  • 1Unit of Internal Medicine, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy.

Insights

Three vessel disease (3VD) significantly increases mortality risk. Low estimated glomerular filtration rate (eGFR) further amplifies this risk, highlighting kidney disease as a critical multiplier for cardiovascular mortality.

Area of Science:

  • Cardiology
  • Nephrology
  • Public Health

Background:

  • Three vessel disease (3VD) is linked to poorer prognosis and increased mortality.
  • Chronic kidney disease (CKD) independently elevates the risk of premature death, primarily from coronary artery disease (CAD).

Purpose of the Study:

  • To assess the prognostic impact of 3VD on all-cause mortality in high-risk patients undergoing coronary angiography (CA).
  • To investigate if reduced estimated glomerular filtration rate (eGFR) modifies the mortality risk associated with 3VD.

Main Methods:

  • 1017 patients undergoing CA (2016-2018) were analyzed.
  • Patients were categorized by CAD severity (3VD vs. no 3VD) and eGFR levels.
  • Mortality risk was analyzed across four groups based on 3VD and low eGFR status.

Main Results:

  • The study included 1017 patients (759 male, mean age 68.4 ± 11 years).
  • Over a median follow-up of 44 months, 114 deaths occurred.
  • 3VD nearly doubled the risk of death (adjusted HR=1.61). Patients with both low eGFR and 3VD faced the highest mortality risk (adjusted HR=3.88).

Conclusions:

  • Low eGFR significantly exacerbates the all-cause mortality risk in patients with 3VD.
  • Kidney disease acts as a potent risk multiplier for both cardiovascular and overall mortality.
  • Preventing CKD onset and progression is crucial for reducing cardiovascular mortality.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
76
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
64
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
473
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
18
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
41
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
388